Training program for developing new cancer drugs for children and adults
Pediatric and Adult Translational Cancer Drug Discovery and Development Training Program (PACT-D3)
This study is all about training new researchers to find better cancer treatments for both kids and adults, especially for children with tough-to-treat tumors, so they can help improve care and options for young patients.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10915428 on NIH RePORTER |
What this research studies
This program trains the next generation of researchers in the field of cancer drug discovery and development, focusing on both pediatric and adult cancers. It aims to address the critical need for effective treatments, particularly for children with relapsed malignant tumors, by leveraging a strong institutional infrastructure and expertise. Participants will engage in comprehensive training that combines basic and clinical research approaches, with a special emphasis on innovative strategies for drug development. The program also collaborates with ongoing clinical trials to enhance treatment options for pediatric patients.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include children and adults diagnosed with cancer, particularly those with relapsed tumors or limited treatment options.
Not a fit: Patients with non-cancerous conditions or those who are not currently undergoing treatment for cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective cancer treatments for both children and adults.
How similar studies have performed: This approach is novel as there are currently no other NIH T32 programs focusing on both pediatric and adult cancer drug discovery and development training.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Kelley, Mark R. — Indiana University Indianapolis
- Study coordinator: Kelley, Mark R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.